Pulsion Medical Systems SE 0NFX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- €0.00 / €0.00
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Pulsion Medical Systems SE operates with its business units hemodynamic monitoring which is engaged in developing, manufacturing, and sale of systems used to monitor, diagnose, and manage physical parameters of patients in intensive care unit, and perfusion imaging which is engaged in developing, manufacturing, and sale of indocyanine green and complementary devices to visualize micro perfusion. The technology developed by the company for critical care are picco, proaqt, limon technology, and eirus technology.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 66
- Website
- http://www.pulsion.com
Comparables
Valuation
Metric
|
0NFX
|
CHG
|
M7U
|
---|---|---|---|
Price/Earnings (Normalized) | — | 1,991.06 | 30.28 |
Price/Book Value | — | 4.11 | 2.14 |
Price/Sales | — | 6.56 | 1.61 |
Price/Cash Flow | — | 34.32 | 17.87 |
Price/Earnings
0NFX
CHG
M7U
Financial Strength
Metric
|
0NFX
|
CHG
|
M7U
|
---|---|---|---|
Quick Ratio | 1.20 | 2.54 | 1.36 |
Current Ratio | 1.93 | 3.00 | 2.47 |
Interest Coverage | 5,475.87 | −2.35 | 14.38 |
Quick Ratio
0NFX
CHG
M7U
Profitability
Metric
|
0NFX
|
CHG
|
M7U
|
---|---|---|---|
Return on Assets (Normalized) | 22.01% | 0.11% | 5.83% |
Return on Equity (Normalized) | 31.17% | 0.21% | 10.40% |
Return on Invested Capital (Normalized) | 31.06% | 1.14% | 7.67% |
Return on Assets
0NFX
CHG
M7U
Medical Devices Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ABT
| Abbott Laboratories | Hlmysgh | Yvpkln | $182.3 Bil | |
SYK
| Stryker Corp | Zvfsqqfvyx | Xtkhr | $123.5 Bil | |
MDT
| Medtronic PLC | Swbpzgv | Hztbrh | $111.9 Bil | |
BSX
| Boston Scientific Corp | Hfpdpbkx | Cqnyvp | $108.0 Bil | |
EW
| Edwards Lifesciences Corp | Xxkfzpvghp | Rmhnvpw | $52.1 Bil | |
DXCM
| DexCom Inc | Jdwdwzbd | Tnkgb | $49.5 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Gjjqrwllg | Gfncc | $24.7 Bil | |
PHG
| Koninklijke Philips NV ADR | Skdjvskl | Dwbjzg | $24.5 Bil | |
ALGN
| Align Technology Inc | Dpyrhmqz | Knsvf | $20.5 Bil | |
PODD
| Insulet Corp | Nytnxcwny | Wqmwgw | $11.3 Bil |